Accounting for Stock Compensation	3 Months Ended
Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Accounting for Stock Compensation	NOTE 12 – ACCOUNTING FOR STOCK COMPENSATION On April 4, 2018, the Company’s board of directors approved the 2018 Omnibus Incentive Plan (the “2018 Omnibus Plan”), which was subsequently approved by the stockholders and became effective on May 31, 2018 (the “Effective Date”). The 2018 Omnibus Plan replaced the previous 2010 Omnibus Incentive Plan (the “Prior Plan”). On or after the Effective Date, the 2018 Omnibus Plan allows the Company to grant 1,185,000 shares using stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance units and performance share awards (“PSAs”), and other stock-based awards to all officers, key employees, and non-employee directors of the Company. Outstanding shares granted under the Prior Plan, totaling 109,832 as of March 31, 2020, remain subject to its terms and conditions, and no additional awards from the Prior Plan are to be made after the Effective Date. As of March 31, 2020, the Company had approximately 669,643 shares available for grant under the 2018 Omnibus Plan. The 2018 Omnibus Plan also gives the Company the ability to issue cash-settled RSUs (“CSRSUs”). The CSRSUs have no impact on the shares available for grant under the Omnibus Plan, nor on the calculated shares used in earnings per share calculations. During the three months ended March 31, 2020, the Company granted to its employees 164,468 shares in the form of RSUs with an average grant date fair value of $57.76, and the equivalent value of 110,895 shares in the form of CSRSUs with an average grant date fair value of $57.76. During the three months ended March 31, 2020, the Company also granted 55,264 shares in the form of PSAs to its employees with a grant date fair value of $58.76 per share. The RSUs, CSRSUs and PSAs granted are generally subject to service-based vesting conditions, with the PSAs also having performance-based vesting conditions. The performance conditions for the PSAs granted in 2020 have a performance period from January 1, 2020 through December 31, 2022 and the performance conditions are consistent with the PSAs granted in prior years. The Company recognized stock-based compensation expense of $5.1 million and $6.7 million for the three months ended March 31, 2020 and 2019, respectively. Unrecognized compensation expense of approximately $20.6 million as of March 31, 2020 related to unsettled RSUs is expected to be recognized over a weighted-average period of 2.41 years. The unrecognized compensation expense related to CSRSUs totaled approximately $11.7 million at March 31, 2020 and is expected to be recognized over a weighted-average period of 2.1 years. Unrecognized compensation expense related to PSAs of approximately $6.5 million as of March 31, 2020 is expected to be recognized over a weighted-average period of 1.8 years.

Accounting for Stock Compensation

3 Months Ended

Mar. 31, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

NOTE 12 – ACCOUNTING FOR STOCK COMPENSATION

On April 4, 2018, the Company’s board of directors approved the 2018 Omnibus Incentive Plan (the “2018 Omnibus Plan”), which was subsequently approved by the stockholders and became effective on May 31, 2018 (the “Effective Date”). The 2018 Omnibus Plan replaced the previous 2010 Omnibus Incentive Plan (the “Prior Plan”).

On or after the Effective Date, the 2018 Omnibus Plan allows the Company to grant 1,185,000 shares using stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance units and performance share awards (“PSAs”), and other stock-based awards to all officers, key employees, and non-employee directors of the Company. Outstanding shares granted under the Prior Plan, totaling 109,832 as of March 31, 2020, remain subject to its terms and conditions, and no additional awards from the Prior Plan are to be made after the Effective Date. As of March 31, 2020, the Company had approximately 669,643 shares available for grant under the 2018 Omnibus Plan. The 2018 Omnibus Plan also gives the Company the ability to issue cash-settled RSUs (“CSRSUs”). The CSRSUs have no impact on the shares available for grant under the Omnibus Plan, nor on the calculated shares used in earnings per share calculations.

During the three months ended March 31, 2020, the Company granted to its employees 164,468 shares in the form of RSUs with an average grant date fair value of $57.76, and the equivalent value of 110,895 shares in the form of CSRSUs with an average grant date fair value of $57.76. During the three months ended March 31, 2020, the Company also granted 55,264 shares in the form of PSAs to its employees with a grant date fair value of $58.76 per share. The RSUs, CSRSUs and PSAs granted are generally subject to service-based vesting conditions, with the PSAs also having performance-based vesting conditions. The performance conditions for the PSAs granted in 2020 have a performance period from January 1, 2020 through December 31, 2022 and the performance conditions are consistent with the PSAs granted in prior years.

The Company recognized stock-based compensation expense of $5.1 million and $6.7 million for the three months ended March 31, 2020 and 2019, respectively. Unrecognized compensation expense of approximately $20.6 million as of March 31, 2020 related to unsettled RSUs is expected to be recognized over a weighted-average period of 2.41 years. The unrecognized compensation expense related to CSRSUs totaled approximately $11.7 million at March 31, 2020 and is expected to be recognized over a weighted-average period of 2.1 years. Unrecognized compensation expense related to PSAs of approximately $6.5 million as of March 31, 2020 is expected to be recognized over a weighted-average period of 1.8 years.